Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort

AIDS

Volumn 28, Issue 17, 2014, Pages 2505-2515

  Fitzpatrick, Meghan E ^a   Singh, Vikas ^a   Bertolet, Marnie ^b   Lucht, Lorrie ^a   Kessinger, Cathy ^a   Michel, Joshua ^a   Logar, Alison ^a   Weinman, Renee ^a   McMahon, Deborah ^a   Norris, Karen A ^a   Vallejo, Abbe N ^a   Morris, Alison ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aging; Chronic obstructive; HIV; Inflammation; Pulmonary disease; T lymphocytes

Indexed keywords

C REACTIVE PROTEIN; CD28 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; CYTOKINE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; INFLAMMATION; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SENESCENCE; SPIROMETRY; T LYMPHOCYTE ACTIVATION; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; AGING; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; IMMUNOLOGY; LUNG DISEASES; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE;

ADULT; AGING; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; LUNG DISEASES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; T-LYMPHOCYTES;

EID: 84927720847     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000471     Document Type: Article

References (78)

1. Palella FJ Jr. Delaney KM. Moorman AC. Loveless MO. Fuhrer J. Satten GA. et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-860.
2. Effros RB. Dagarag M. Spaulding C. Man J. The role of CD8R Tcell replicative senescence in human aging. Immunol Rev 2005; 205: 147-157.
3. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep 2010; 7: 69-76.
4. Pathai S. Bajillan H. Landay AL. High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2014; 69: 833-842.
5. Crothers K. Chronic obstructive pulmonary disease in patients who have HIV infection. Clin Chest Med 2007; 28: 575-587vi.
6. Crothers K. Butt AA. Gibert CL. Rodriguez-Barradas MC. Crystal S. Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006; 130: 1326-1333.
7. Crothers K. Huang L. Goulet JL. Goetz MB. Brown ST. Rodriguez-Barradas MC. et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011; 183: 388-395.
8. Diaz PT. King MA. Pacht ER. Wewers MD. Gadek JE. Nagaraja HN. et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000; 132: 369-372.
9. Fitzpatrick ME. Gingo MR. Kessinger C. Lucht L. Kleerup E. Greenblatt RM. et al. HIV infection is associated with diffusing capacity impairment in women. J Acquir Immune Defic Syndr 2013; 64: 284-288.
10. George MP. Kannass M. Huang L. Sciurba FC. Morris A. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One 2009; 4: e6328.
11. Gingo MR. George MP. Kessinger CJ. Lucht L. Rissler B. Weinman R. et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 2010; 182: 790-796.
12. Hirani A. Cavallazzi R. Vasu T. PachinburavanM. KraftWK. Leiby B. et al. Prevalence of obstructive lung disease in HIVpopulation: a cross sectional study. Respir Med 2011; 105: 1655-1661.
13. Kristoffersen US. Lebech AM. Mortensen J. Gerstoft J. Gutte H. Kjaer A. Changes in lung function of HIV-infected patients: a 4.5-year follow-up study. Clin Physiol Funct Imaging 2012; 32: 288-295.
14. Cui Q. Carruthers S. McIvor A. Smaill F. Thabane L. Smieja M. Effect of smoking on lung function. respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a crosssectional study. AIDS Res Ther 2010; 7: 6-16.
15. Gingo MR. George MP. Kessinger CJ. Lucht L. Rissler B. Weinman R. et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 2010; 182: 790-796.
16. Appay V. Papagno L. Spina CA. Hansasuta P. King A. Jones L. et al. Dynamics of T cell responses in HIV infection. J Immunol 2002; 168: 3660-3666.
17. Cao W. Jamieson BD. Hultin LE. Hultin PM. Effros RB. Detels R. Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr 2009; 50: 137-147.
18. Desai S. Landay A. Early immune senescence in HIV disease. Curr HIV/AIDS Rep 2010; 7: 4-10.
19. Lemster BH. Michel JJ. Montag DT. Paat JJ. Studenski SA. Newman AB. et al. Induction of CD56 and TCR-independent activation of T cells with aging. J Immunol 2008; 180: 1979-1990.
20. Vallejo AN. Hamel DL Jr. Mueller RG. Ives DG. Michel JJ. Boudreau RM. et al. NK-like T cells and plasma cytokines. but not antiviral serology. define immune fingerprints of resilience and mild disability in exceptional aging. PLoS One 2011; 6: e26558.
21. Clifford DB. HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med 2008; 16: 94-98.
22. Effros RB. Fletcher CV. Gebo K. Halter JB. Hazzard WR. Horne FM. et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008; 47: 542-553.
23. Wand H. Calmy A. Carey DL. Samaras K. Carr A. Law MG. et al. Metabolic syndrome. cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS 2007; 21: 2445-2453.
24. Bozzette SA. Ake CF. Tam HK. Chang SW. Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348: 702-710.
25. Deeks SG. HIV infection. inflammation. immunosenescence. and aging. Annu Rev Med 2011; 62: 141-155.
26. Aoshiba K. Nagai A. Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6: 596-601.
27. Ito K. Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009; 135: 173-180.
28. Karrasch S. Holz O. Jorres RA. Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med 2008; 102: 1215-1230.
29. Lambers C. Hacker S. Posch M. Hoetzenecker K. Pollreisz A. Lichtenauer M. et al. T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2009; 155: 466-475.
30. MacNee W. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans 2009; 37: 819-823.
31. Tsuji T. Aoshiba K. Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006; 174: 886-893.
32. Hunt PW. Martin JN. Sinclair E. Bredt B. Hagos E. Lampiris H. et al. T cell activation is associated with lower CD4R T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187: 1534-1543.
33. Giorgi JV. Hultin LE. McKeating JA. Johnson TD. Owens B. Jacobson LP. et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179: 859-870.
34. Kaplan RC. Sinclair E. Landay AL. Lurain N. Sharrett AR. Gange SJ. et al. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 2011; 203: 452-463.
35. Kaplan RC. Sinclair E. Landay AL. Lurain N. Sharrett AR. Gange SJ. et al. T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis 2011; 217: 207-213.
36. Merlini E Luzi K. Suardi E. Barassi A. Cerrone M. Martinez JS. et al. T-cell phenotypes. apoptosis and inflammation in HIVR patients on virologically effective cART with early atherosclerosis. PLoS One 2012; 7: e46073.
37. Armah KA. McGinnis K. Baker J. Gibert C. Butt AA. Bryant KJ. et al. HIV status. burden of comorbid disease. and biomarkers of inflammation. altered coagulation. and monocyte activation. Clin Infect Dis 2012; 55: 126-136.
38. Kuller LH. Tracy R. Belloso W. De Wit S. Drummond F. Lane HC. et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5: e203.
39. Duprez DA. Neuhaus J. Kuller LH. Tracy R. Belloso W. De Wit S. et al. Inflammation. coagulation and cardiovascular disease in HIV-infected individuals. PLoS One 2012; 7: e44454.
40. Agusti A. Edwards LD. Rennard SI. MacNee W. Tal-Singer R. Miller BE. et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012; 7: e37483.
41. Gadgil A. Duncan SR. Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008; 3: 531-541.
42. Miller MR. Hankinson J. Brusasco V. Burgos F. Casaburi R. Coates A. et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
43. Macintyre N. Crapo RO. Viegi G. Johnson DC. van der Grinten CP. Brusasco V. et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735.
44. Hankinson JL. Odencrantz JR. Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
45. Neas LM. Schwartz J. The determinants of pulmonary diffusing capacity in a national sample of U.S. adults. Am J Respir Crit Care Med 1996; 153: 656-664.
46. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.
47. Hsue PY. Hunt PW. Sinclair E. Bredt B. Franklin A. Killian M. et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006; 20: 2275-2283.
48. Funderburg NT. Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients. Curr Opin HIV AIDS 2014; 9: 80-86.
49. Lau B. Sharrett AR. Kingsley LA. Post W. Palella FJ. Visscher B. et al. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch InternMed 2006; 166: 64-70.
50. Lacerda HR. Falcao Mda C. de Albuquerque VM. Zirpoli JC. Miranda-FilhoDde B. de AlbuquerqueMde F. et al. Associationof inflammatory cytokines and endothelial adhesion molecules with immunological. virological. and cardiometabolic disease in HIV-infected individuals. J Interferon Cytokine Res 2014; 34: 385-393.
51. Zhang Y. Bunjhoo H. Xiong W. Xu Y. Yang D. Association between C-reactive protein concentration and chronic obstructive pulmonary disease: a systematic review and metaanalysis. J Int Med Res 2012; 40: 1629-1635.
52. Dahl M. Vestbo J. Lange P. Bojesen SE. Tybjaerg-Hansen A. Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.AmJ Respir Crit Care Med 2007; 175: 250-255.
53. ThomsenM. Ingebrigtsen TS. Marott JL. DahlM. Lange P. VestboJ. et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013; 309: 2353-2361.
54. Thomsen M. Dahl M. Lange P. Vestbo J. Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 982-988.
55. Appay V. Almeida JR. Sauce D. Autran B. Papagno L. Accelerated immune senescence and HIV-1 infection. Exp Gerontol 2007; 42: 432-437.
56. Deeks SG. Lewin SR. Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013; 382: 1525-1533.
57. Sharpless NE. DePinho RA. Telomeres. stem cells. senescence. and cancer. J Clin Invest 2004; 113: 160-168.
58. Savale L. Chaouat A. Bastuji-Garin S. Marcos E. Boyer L. Maitre B. et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179: 566-571.
59. Alder JK. Guo N. Kembou F. Parry EM. Anderson CJ. Gorgy AI. et al. Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med 2011; 184: 904-912.
60. Rode L. Bojesen SE. Weischer M. Vestbo J. Nordestgaard BG. Short telomere length. lung function and chronic obstructive pulmonary disease in 46. 396 individuals. Thorax 2013; 68: 429-435.
61. Lee J. Sandford AJ. Connett JE. Yan J. Mui T. Li Y. et al. The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD). PLoS One 2012; 7: e35567.
62. Effros RB. Allsopp R. Chiu CP. Hausner MA. Hirji K. Wang L. et al. Shortened telomeres in the expanded CD28-CD8R cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996; 10: F17-F22.
63. Zanet DL. Thorne A. Singer J. Maan EJ. Sattha B. Le Campion A. et al. Association between short leukocyte telomere length and HIV infection in a cohort study: no evidence of a relationship with antiretroviral therapy. Clin Infect Dis 2014; 58: 1322-1332.
64. Pathai S. LawnSD. Gilbert CE. McGuinness D. McGlynn L. Weiss HA. et al. Accelerated biological ageing in HIV-infected individuals in South Africa: a case-control study. AIDS2013; 27: 2375-2384.
65. Dock JN. Effros RB. Role of CD8 T Cell Replicative senescence in human aging and in HIV-mediated Immunosenescence. Aging Dis 2011; 2: 382-397.
66. Hearps AC. Maisa A. Cheng WJ. Angelovich TA. Lichtfuss GF. Palmer CS. et al. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS 2012; 26: 843-853.
67. Mendez-Lagares G. Garcia-Perganeda A. del Mar del Pozo-BaladoM. Genebat M. Ruiz-Mateos E. Garcia Garcia M. et al. Differential alterations of the CD4 and CD8 T cell subsets in HIVinfected patients on highly active antiretroviral therapy with low CD4 T cell restoration. J Antimicrob Chemother 2012; 67: 1228-1237.
68. Meyer-Olson D. Simons BC. Conrad JA. Smith RM. Barnett L. Lorey SL. et al. Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8Reffector-memory T-cell repertoire in vivo. Blood 2010; 116: 396-405.
69. Vallejo AN. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005; 205: 158-169.
70. Vallejo AN. Weyand CM. Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 2004; 10: 119-124.
71. Dvergsten JA. Mueller RG. Griffin P. Abedin S. Pishko A. Michel JJ. et al. Premature cell senescence and T cell receptor-independent activation of CD8R T cells in juvenile idiopathic arthritis. Arthritis Rheum 2013; 65: 2201-2210.
72. Michel JJ. Turesson C. Lemster B. Atkins SR. Iclozan C. Bongartz T. et al. CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis. Arthritis Rheum 2007; 56: 43-57.
73. Griffin P. Michel JJ. Huysman K. Logar AJ. Vallejo AN. Integration of immunity with physical and cognitive function in definitions of successful aging. Aging Dis 2012; 3: 34-50.
74. Lee SA. Sinclair E. Jain V. Huang Y. Epling L. Van Natta M. et al. Low Proportions of CD28-CD8R T cells Expressing CD57 Can Be Reversed by Early ART Initiation and Predict Mortality in Treated HIV Infection. J Infect Dis 2014; 210: 374-382.
75. Maeno T. Houghton AM. Quintero PA. Grumelli S. Owen CA. Shapiro SD. CD8R T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol 2007; 178: 8090-8096.
76. Grumelli S. Corry DB. Song LZ. Song L. Green L. Huh J. et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004; 1: e8.
77. Lee N. Shin MS. Kang I. T-cell biology in aging. with a focus on lung disease. J Gerontol A Biol Sci Med Sci 2012; 67: 254-263.
78. Cosio MG. Majo J. Cosio MG. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002; 121: 160S-165S.